dipyridamole has been researched along with Immunologic Deficiency Syndromes in 3 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Immunologic Deficiency Syndromes: Syndromes in which there is a deficiency or defect in the mechanisms of immunity, either cellular or humoral.
| Excerpt | Relevance | Reference |
|---|---|---|
| "4) is markedly toxic to lymphoblast cell lines of T cell origin but does not impair growth of B cell lines." | 1.26 | Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells. ( Daddona, PE; Kelley, WN; Mejias, E; Mitchell, BS, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ammann, AJ | 1 |
| Cowan, MJ | 1 |
| Martin, DW | 1 |
| Wara, DW | 1 |
| Mitchell, BS | 1 |
| Mejias, E | 1 |
| Daddona, PE | 1 |
| Kelley, WN | 1 |
| Sierakowski, S | 1 |
1 review available for dipyridamole and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
[New theories on the pathogenesis and methods of treating thrombotic thrombocytopenic purpura (Moschkowitz disease)].
Topics: Adolescent; Adult; Aspirin; Blood Coagulation Disorders; Child; Dipyridamole; Epoprostenol; Female; | 1986 |
2 other studies available for dipyridamole and Immunologic Deficiency Syndromes
| Article | Year |
|---|---|
Dipyridamole and intravenous deoxycytidine therapy in a patient with adenosine deaminase deficiency.
Topics: Adenosine Deaminase; Administration, Oral; Child; Cytidine Deaminase; Deoxycytidine; Dipyridamole; D | 1983 |
Purinogenic immunodeficiency diseases: selective toxicity of deoxyribonucleosides for T cells.
Topics: B-Lymphocytes; Cell Line; Deoxyadenine Nucleotides; Deoxyadenosines; Deoxycytidine; Deoxyguanine Nuc | 1978 |